Literature DB >> 14690536

Expression of SOD1 G93A or wild-type SOD1 in primary cultures of astrocytes down-regulates the glutamate transporter GLT-1: lack of involvement of oxidative stress.

Massimo Tortarolo1, Andrew J Crossthwaite, Laura Conforti, Jeremy P Spencer, Robert J Williams, Caterina Bendotti, Marcus Rattray.   

Abstract

Glutamate excitotoxicity is implicated in the aetiology of amyotrophic lateral sclerosis (ALS) with impairment of glutamate transport into astrocytes a possible cause of glutamate-induced injury to motor neurons. It is possible that mutations of Cu/Zn superoxide dismutase (SOD1), responsible for about 20% of familial ALS, down-regulates glutamate transporters via oxidative stress. We transfected primary mouse astrocytes to investigate the effect of the FALS-linked mutant hSOD1(G93A) and wild-type SOD1 (hSOD1wt) on the glutamate uptake system. Using western blotting, immunocytochemistry and RT-PCR it was shown that expression of either hSOD1(G93A) or hSOD1wt in astrocytes produced down-regulation of the levels of a glutamate transporter GLT-1, without alterations in its mRNA level. hSOD1(G93A) or hSOD1wt expression caused a decrease of the monomeric form of GLT-1 without increasing oxidative multimers of GLT-1. The effects were selective to GLT-1, since another glutamate transporter GLAST protein and mRNA levels were not altered. Reflecting the decrease in GLT-1 protein, [3H]d-aspartate uptake was reduced in cultures expressing hSOD1(G93A) or hSOD1wt. The hSOD1-induced decline in GLT-1 protein and [3H]d-aspartate uptake was not blocked by the antioxidant Trolox nor potentiated by antioxidant depletion using catalase and glutathione peroxidase inhibitors. Measurement of 2',7'-dichlorofluorescein (DCF)-induced fluorescence revealed that expression of hSOD1(G93A) or hSOD1wt in astrocytes does not lead to detectable increase of intracellular reactive oxygen species. This study suggests that levels of GLT-1 protein in astrocytes are reduced rapidly by overexpression of hSOD1, and is due to a property shared between the wild-type and G93A mutant form, but does not involve the production of intracellular oxidative stress.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14690536     DOI: 10.1046/j.1471-4159.2003.02208.x

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  22 in total

Review 1.  Reversal or reduction of glutamate and GABA transport in CNS pathology and therapy.

Authors:  Nicola J Allen; Ragnhildur Káradóttir; David Attwell
Journal:  Pflugers Arch       Date:  2004-08-24       Impact factor: 3.657

2.  The four major N- and C-terminal splice variants of the excitatory amino acid transporter GLT-1 form cell surface homomeric and heteromeric assemblies.

Authors:  Eleanor Peacey; Christopher C J Miller; John Dunlop; Marcus Rattray
Journal:  Mol Pharmacol       Date:  2009-02-06       Impact factor: 4.436

Review 3.  The role of astrocytic glutamate transporters GLT-1 and GLAST in neurological disorders: Potential targets for neurotherapeutics.

Authors:  Edward Pajarillo; Asha Rizor; Jayden Lee; Michael Aschner; Eunsook Lee
Journal:  Neuropharmacology       Date:  2019-03-06       Impact factor: 5.250

4.  HSPB1 mutations causing hereditary neuropathy in humans disrupt non-cell autonomous protection of motor neurons.

Authors:  Patrick L Heilman; SungWon Song; Carlos J Miranda; Kathrin Meyer; Amit K Srivastava; Amy Knapp; Christopher G Wier; Brian K Kaspar; Stephen J Kolb
Journal:  Exp Neurol       Date:  2017-08-07       Impact factor: 5.330

Review 5.  Advances in cellular models to explore the pathophysiology of amyotrophic lateral sclerosis.

Authors:  C Veyrat-Durebex; P Corcia; A Dangoumau; F Laumonnier; E Piver; P H Gordon; C R Andres; P Vourc'h; H Blasco
Journal:  Mol Neurobiol       Date:  2013-11-07       Impact factor: 5.590

6.  Astrocytes Grown in Alvetex(®) Three Dimensional Scaffolds Retain a Non-reactive Phenotype.

Authors:  Christopher I Ugbode; Warren D Hirst; Marcus Rattray
Journal:  Neurochem Res       Date:  2016-04-21       Impact factor: 3.996

7.  Specific induction of Akt3 in spinal cord motor neurons is neuroprotective in a mouse model of familial amyotrophic lateral sclerosis.

Authors:  Marco Peviani; Massimo Tortarolo; Elisa Battaglia; Roberto Piva; Caterina Bendotti
Journal:  Mol Neurobiol       Date:  2013-07-20       Impact factor: 5.590

8.  Neuron-astrocyte interactions in neurodegenerative diseases: Role of neuroinflammation.

Authors:  Kakulavarapu V Rama Rao; Tammy Kielian
Journal:  Clin Exp Neuroimmunol       Date:  2015-08-03

Review 9.  Glutamate transporters and the excitotoxic path to motor neuron degeneration in amyotrophic lateral sclerosis.

Authors:  Emily Foran; Davide Trotti
Journal:  Antioxid Redox Signal       Date:  2009-07       Impact factor: 8.401

10.  Effects of Cu/Zn superoxide dismutase on estrogen responsiveness and oxidative stress in human breast cancer cells.

Authors:  Abhi K Rao; Yvonne S Ziegler; Ian X McLeod; John R Yates; Ann M Nardulli
Journal:  Mol Endocrinol       Date:  2008-02-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.